chr3-46701546-T-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_147196.3(TMIE):c.59T>A(p.Val20Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000216 in 1,292,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V20L) has been classified as Uncertain significance.
Frequency
Consequence
NM_147196.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMIE | NM_147196.3 | c.59T>A | p.Val20Glu | missense_variant | 1/4 | ENST00000643606.3 | |
TMIE | NM_001370524.1 | c.-66-4244T>A | intron_variant | ||||
TMIE | NM_001370525.1 | c.-66-4244T>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMIE | ENST00000643606.3 | c.59T>A | p.Val20Glu | missense_variant | 1/4 | NM_147196.3 | P1 | ||
TMIE | ENST00000644830.1 | c.-66-4244T>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00105 AC: 160AN: 151822Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00242 AC: 2AN: 826Hom.: 0 AF XY: 0.00490 AC XY: 2AN XY: 408
GnomAD4 exome AF: 0.000104 AC: 119AN: 1140962Hom.: 0 Cov.: 30 AF XY: 0.000101 AC XY: 55AN XY: 545622
GnomAD4 genome AF: 0.00105 AC: 160AN: 151934Hom.: 0 Cov.: 32 AF XY: 0.00105 AC XY: 78AN XY: 74270
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 18, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 19, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at